CAUTI Prevention Urology Products Market Is Likely To Witness Huge Growth
The global CAUTI prevention urology products market size was valued at USD 3.43 billion in 2025 and is projected to reach USD 6.05 billion by 2033, growing at a CAGR of 7.35% from 2026 to 2033.
CAUTI Prevention Urology Products Market Summary
The global CAUTI prevention urology products market was valued at USD 3.43 billion in 2025 and is expected to grow significantly, reaching USD 6.05 billion by 2033. This growth reflects a steady compound annual growth rate (CAGR) of 7.35% from 2026 to 2033. The expansion of this market is primarily driven by the increasing occurrence of catheter-associated urinary tract infections (CAUTIs) worldwide. Additionally, there is a growing emphasis on maintaining strict infection control practices across healthcare environments, which is further encouraging the demand for advanced urology products designed to prevent infections.
The presence of stringent regulatory frameworks and proactive hospital initiatives aimed at minimizing hospital-acquired infections has played a crucial role in boosting the adoption of antimicrobial and technologically advanced safety-enhanced urology products. Healthcare providers are increasingly prioritizing patient safety, leading to a higher demand for effective prevention solutions. Furthermore, the rise in hospitalization rates, coupled with a rapidly aging population, has significantly increased the use of urinary catheters in both acute care and long-term care settings. These factors collectively contribute to the sustained growth of the market. The increasing prevalence of CAUTIs, along with other hospital-acquired infections, continues to act as a major driving force behind the expansion of the CAUTI prevention urology products market.
Key Market Trends & Insights
- North America held the leading position in the CAUTI prevention urology products market, accounting for the highest revenue share of 37.76% in 2025.
- Within North America, the United States represented the largest contributor to market revenue in 2025, maintaining its dominant position in the region.
- Based on product type, the preventive drainage devices (Primary Prevention) segment emerged as the leading category, capturing the highest revenue share in 2025 due to its critical role in infection prevention.
- In terms of application, the urinary incontinence management segment dominated the market in 2025, supported by the increasing prevalence of incontinence-related conditions and the need for effective management solutions.
- By end use, the hospitals segment accounted for the largest revenue share in 2025, driven by high patient inflow, increased catheter usage, and the implementation of strict infection control protocols.
Order a free sample PDF of the CAUTI Prevention Urology Products Market Intelligence Study, published by Grand View Research.
Market Size & Forecast
- 2025 Market Size: USD 3.43 Billion
- 2033 Projected Market Size: USD 6.05 Billion
- CAGR (2026-2033): 7.35%
- North America: Largest market in 2025
Key Companies & Market Share Insights
The market is dominated by leading medical device companies with extensive product portfolios and strong distribution networks. Key players focus on advanced antimicrobial catheters, sterile drainage systems, and mechanical prevention solutions, capturing major market share in hospitals and long-term care settings. Both global and regional companies actively drive the market through innovation, partnerships, and strategic expansions.
Key Players
- BD
- Braun SE
- Coloplast
- Teleflex Incorporated
- Cook Medical
- Medtronic
- Hollister Incorporated
- ConvaTec Group PLC
- Boston Scientific Corporation
- Cardinal Health
- Merit Medical
- Medline Industries, LP.
- Poiesis Medical LLC
Conclusion
The CAUTI prevention urology products market is poised for substantial growth over the coming years, driven by a combination of rising infection rates, increasing healthcare awareness, and continuous advancements in medical technology. The growing focus on patient safety and infection prevention has encouraged healthcare institutions to adopt more effective and innovative solutions. Additionally, demographic trends such as an aging population and higher hospitalization rates are further strengthening market demand. Regional dominance by North America highlights the importance of advanced healthcare infrastructure and regulatory support. Overall, the market is expected to witness steady expansion, supported by ongoing innovation and increased global emphasis on quality healthcare practices.